Gamida Cell Ltd (fka GMDAQ)

[murocman]

Yes, I understand. I don’t think the FDA pays very much attention to management though.

I agree they’re a mess, and raise concerns about how the company successfully executed if they do get approval.

As far as asking for more details, that should have been handled during the PDUFA extension period.

I don’t dispute there’s risk here. All small biotech stocks are risky. I do think the compelling efficacy and safety win the day and approval.

If that happens, there’s a much higher likelihood of a partnership or buyout as they will have a valuable asset.

Murocman